Intervention Review

Finasteride for benign prostatic hyperplasia

  1. James Tacklind1,*,
  2. Howard A Fink2,
  3. Roderick MacDonald3,
  4. Indy Rutks3,
  5. Timothy J Wilt3

Editorial Group: Cochrane Urology Group

Published Online: 6 OCT 2010

Assessed as up-to-date: 5 FEB 2009

DOI: 10.1002/14651858.CD006015.pub3


How to Cite

Tacklind J, Fink HA, MacDonald R, Rutks I, Wilt TJ. Finasteride for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews 2010, Issue 10. Art. No.: CD006015. DOI: 10.1002/14651858.CD006015.pub3.

Author Information

  1. 1

    Independent contractor, Minneapolis, Minnesota, USA

  2. 2

    Minneapolis VA Medical Center, Geriatric Research Education and Clinical Center, Box 11G, Minneapolis, Minnesota, USA

  3. 3

    Minneapolis VA Medical Center, General Internal Medicine (111-0), Minneapolis, Minnesota, USA

*James Tacklind, Independent contractor, Minneapolis, Minnesota, USA. jtacklind1@msn.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 6 OCT 2010

SEARCH

  1. Current Version

    Finasteride for benign prostatic hyperplasia

    James Tacklind, Howard A Fink, Roderick MacDonald, Indy Rutks and Timothy J Wilt

    Version of Record online: 6 OCT 2010 | DOI: 10.1002/14651858.CD006015.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Finasteride for benign prostatic hyperplasia

    James Tacklind, Howard A Fink, Roderick MacDonald, Indy Rutks and Timothy J. Wilt

    Version of Record online: 8 JUL 2009 | DOI: 10.1002/14651858.CD006015.pub2

  2. Version 1

    Finasteride for benign prostatic hyperplasia

    Carlos Tello Royloa, Enrique Cao Avellaneda, Pedro López Cubillana and Mariano Rigabert Montiel

    Version of Record online: 19 APR 2006 | DOI: 10.1002/14651858.CD006015